en
img

NAVITAE® PLUS

PROTECTS AND SOOTHES THE OCULAR SURFACE

Indicated for :

NAVITAE® PLUS is a lubricant ophthalmic solution with an antioxidant and moisturizing effect used for the relief of dry eyes and ocular discomfort caused by :

- Ocular irritation caused by pathologies such as keratitis, adverse effects following corneal surgery, traumatic ulcers, corneal inflammation.

- Oxidative stress due to light exposure and/or an increase in free radicals on the ocular surface.

- Contact lens wearing.

WITH SODIUM HYALURONATE 0.15%

- A highly hydrophilic physiological polymer.

- Provides NAVITAE® PLUS with biophysical properties similar to those of natural tears.

- Has an optimum molecular weight.

WITH CARBOXYMETHYL ß-GLUCAN

- A viscoelastic agent

- Lubricating effect

WITH VITAMIN A

- Stabilizes the fatty phase of the tear film

- Helps to maintain natural hydration

- Reduces the symptoms of ocular dryness

WITH VITAMIN E

- Antioxidant

- Reduces the concentration of free radicals in the lachrymal fluid

- Enhances the protection of corneal and conjunctival epithelial cells

- Decreases the risk of inflammation

AND WITH SCO®

NAVITAE® PLUS is preserved with a special preservative system called SCO® (Stabilized Complex Oxychloro) that keeps the solution sterile in the bottle. When exposed to light, SCO® dissipates into components naturally found in human tears such as sodium chloride, oxygen and water, making it very well tolerated.

♦ The topical ocular use of Vitamin A improves contact lens wearing by reducing the frictional, mechanical damage that they can cause on epithelial cells of the cornea and conjunctiva. Vitamin A stabilizes the fatty phase of the lachrymal film by increasing its capacity to maintain natural hydration, therefore reducing the symptoms of ocular dryness.

♦ This activity is also exerted by the polysaccharides present in the product.

♦ Vitamin E is an antioxidant that helps to reduce the concentration of free radicals in the lachrymal fluid, and therefore enhances the protection of corneal and conjunctival epithelial cells, decreasing the risk of inflammation.



> Brochure ( Pdf pdf )

> Guide ( Pdf pdf )

> Leaflet ( Pdf pdf )